↓ Skip to main content

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Overview of attention for article published in Lancet Infectious Diseases, November 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#7 of 4,524)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
364 news outlets
blogs
14 blogs
twitter
1569 tweeters
wikipedia
2 Wikipedia pages
reddit
2 Redditors
video
4 video uploaders

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
170 Mendeley
Title
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Published in
Lancet Infectious Diseases, November 2020
DOI 10.1016/s1473-3099(20)30843-4
Pubmed ID
Authors

Yanjun Zhang, Gang Zeng, Hongxing Pan, Changgui Li, Yaling Hu, Kai Chu, Weixiao Han, Zhen Chen, Rong Tang, Weidong Yin, Xin Chen, Yuansheng Hu, Xiaoyong Liu, Congbing Jiang, Jingxin Li, Minnan Yang, Yan Song, Xiangxi Wang, Qiang Gao, Fengcai Zhu

Twitter Demographics

The data shown below were collected from the profiles of 1,569 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 170 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 170 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 29 17%
Researcher 26 15%
Unspecified 18 11%
Student > Master 18 11%
Student > Doctoral Student 13 8%
Other 51 30%
Unknown 15 9%
Readers by discipline Count As %
Medicine and Dentistry 49 29%
Biochemistry, Genetics and Molecular Biology 23 14%
Unspecified 19 11%
Immunology and Microbiology 15 9%
Pharmacology, Toxicology and Pharmaceutical Science 9 5%
Other 37 22%
Unknown 18 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 4165. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 January 2021.
All research outputs
#465
of 16,663,134 outputs
Outputs from Lancet Infectious Diseases
#7
of 4,524 outputs
Outputs of similar age
#67
of 367,158 outputs
Outputs of similar age from Lancet Infectious Diseases
#2
of 180 outputs
Altmetric has tracked 16,663,134 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,524 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 59.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,158 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 180 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.